CrushSCI.com
提供学术论文选刊润色服务
EJNMMI Research 期刊封面 医学
返回期刊列表

Review Cycle Records

EJNMMI Research

Springer SCIE OA
2026新锐 3区2025中科院 3区2025 JCR Q2
126.5平均天数
122中位天数
41最短天数
190最长天数
1652025发文量

Paper Review Records

全部论文审稿周期

10 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接

176 天

Correlation of [ 18 F]SiTATE-PET-tracer with somatostatin receptor expression in meningiomas: an exploratory ex vivo histological pilot study

作者Rieke Gerdes; Jens Schittenhelm; Stephan Singer; Gerald Reischl; Hannes Becker; Marcos Tatagiba; Salvador G. Castaneda-Vega; Christian la Fougère; Benjamin Bender; Nils F. Trautwein

作者单位1. Department of Nuclear Medicine and Clinical Molecular Imaging, University Hospital Tuebingen, Tuebingen, Germany; 2. Institute of Neuropathology, Department of Pathology and Neuropathology, University Hospital Tuebingen, Tuebingen, Germany; 3. Department of General and Molecular Pathology and Pathological Anatomy, University Hospital Tuebingen, Tuebingen, Germany; 4. Department of Preclinical Imaging and Radiopharmacy, University Hospital Tuebingen, Tuebingen, Germany; 5. Department of Neurosurgery, University Hospital Tuebingen, Tuebingen, Germany; 6. Department of Neurology and Interdisciplinary Neuro-Oncology, University Hospital Tuebingen, Hertie Institute for Clinical Brain Research, Eberhard Karls University Tuebingen, Tuebingen, Baden-Wuerttemberg, Germany; 7. DFG Cluster of Excellence 2180 ‘Image-Guided and Functional Instructed Tumor Therapy’ (iFIT), University of Tuebingen, Tuebingen, Germany; 8. German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ) Partner Site Tuebingen, Tuebingen, Germany; 9. Department of Neuroradiology, University Hospital Tuebingen, Tuebingen, Germany

PDF源文件 DOI 网页
115 天

[ 18 F]FDG PET/CT as an endpoint marker in drug interventional studies in atherosclerosis - a structured review

作者Casper E. W. Gijsen; Felix M. Mottaghy; Ahmed Tawakol; Joachim E. Wildberger; Jan Bucerius

作者单位1. Department of Radiology and Nuclear Medicine, Maastricht University Medical Center (MUMC⁺), Maastricht, the Netherlands; 2. Department of Nuclear Medicine, University Hospital RWTH Aachen, Aachen, Germany; 3. Cardiovascular Imaging Research Center, Massachusetts General Hospital, Boston, USA; 4. Department of Medicine, Division of Cardiology, Massachusetts General Hospital, Boston, USA; 5. Cardiovascular Research Institute (CARIM), Maastricht University Medical Center (MUMC⁺), Maastricht, the Netherlands; 6. Division of Nuclear Medicine, Department of Radiology, Medical University of Graz, Graz, Austria

PDF源文件 DOI 网页
41 天

Biodistribution and dosimetry of the carbon-11 labelled PARP1-selective PET radiopharmaceutical [ 11 C]AZ14193391

作者Anders Törnblom; Cecilia He; Martin Bolin; Antonios Tzortzakakis; Josefin Fernebro; Chunde Li; Susanne Fridsten; Renske Altena; Rimma Axelsson; Jonathan Siikanen; Cecilia Hindorf

作者单位1. Department of Nuclear Medicine and Medical Physics Nuclear Medicine, Karolinska University Hospital, Stockholm, Sweden; 2. Division of Molecular Medicine and Surgery (MMK), Karolinska Institutet, Stockholm, Sweden; 3. Division of Radiology Department for Clinical Science Intervention and Technology (CLINTEC), Karolinska Institutet, Stockholm, Sweden; 4. Centre for Psychiatry Research Department of Clinical Neuroscience, Karolinska Institutet & Stockholm Health Care Services Region, Stockholm, Sweden; 5. Department of Nuclear Medicine and Medical Physics Theranostics Trial Center, Karolinska University Hospital, Stockholm, Sweden; 6. Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden; 7. Section of Gynecological Oncology, Karolinska University Hospital, Stockholm, Sweden; 8. Department of Oncology, Södersjukhuset, Stockholm, Sweden; 9. Department of Clinical Science and Education, Karolinska Institutet Södersjukhuset, Stockholm, Sweden

PDF源文件 DOI 网页
132 天

Evaluation of the biodistribution of [ 99m Tc]Tc-PSMA-GCK01 SPECT/CT in a prospective, intraindividual comparison with [ 68 Ga]PSMA-11 PET/CT for phenotyping in mCRPC prior to PSMA-targeted radioligand therapy

作者Emil Novruzov; Eduards Mamlins; Joseph Kabunda; Jens Cardinale; Milani Qebetu; Clemens Kratochwil; Anna Feisthauer; Stefan Martlbauer; Chimbabantu Alexis Kaoma; Sandile Sibiya; Tertia de Bruin; Sipho Mdanda; Mbongeni Shungube; Cindy Davis; Liani Smith; Yonwaba Mzizi; Kgomotso Mokoala; Honest Ndlovu; Keamogetswe Ramonaheng; Frederik L. Giesel; Mike M Sathekge

作者单位1. Department of Nuclear Medicine, Medical Faculty and University Hospital Duesseldorf, Heinrich-Heine-University Duesseldorf, Duesseldorf, Germany; 2. Centre for Integrated Oncology (CIO) Duesseldorf, CIO Aachen-Bonn-Cologne-Duesseldorf, Duesseldorf, Germany; 3. Department of Nuclear Medicine, University of Pretoria and Steve Biko Academic Hospital, Pretoria, South Africa; 4. Nuclear Medicine Research Infrastructure (NuMeRI), Pretoria, South Africa; 5. Department of Nuclear Medicine, University Hospital Heidelberg, Heidelberg, Germany

PDF源文件 DOI 网页
98 天

[ 161 Tb]Tb-DOTATATE as a potential treatment option for neuroblastoma

作者Saloni Chopra; Tianqi Xu; Hanna Berglund; Amanda Gustafsson; Marika Nestor

作者单位1. Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden

PDF源文件 DOI 网页
117 天

Early detection and localization of recurrent prostate cancer using \(^{18}\) F-DCFPyL PET/CT in patients with low and ultra-low PSA levels

作者Ida Sonni; Alexandra Gulpe; Nicholas G. Nickols; Derace Schaffer; Louis Montagut; Gholam R. Berenji; Matthew B. Rettig

作者单位1. Department of Radiological Sciences, University of California, Los Angeles, USA; 2. Department of Nuclear Medicine, VA Greater Los Angeles Healthcare System, Los Angeles, USA; 3. EXINI Diagnostics AB, Lund, Sweden; 4. Department of Radiation Oncology, University of California, Los Angeles, USA; 5. Department of Radiation Oncology, VA Greater Los Angeles Healthcare System, Los Angeles, USA; 6. Department of Urology, University of California, Los Angeles, USA; 7. Concord Academy, Concord, USA; 8. Department of Medicine, University of California, Los Angeles, USA; 9. Department of Medicine, Division of Hematology-Oncology, VA Greater Los Angeles Healthcare System, Los Angeles, USA

PDF源文件 DOI 网页
162 天

Head-to-head comparison of 99m Tc-MIP-1404 CZT SPECT/CT and 68 Ga/PSMA-11 PET/CT for primary staging of high-risk prostate cancer: a phase II study

作者Aws Saudi; Malin Ståhlgren; Prab Takhar; Pernilla Norberg; Martin Holmbom; Julia Dahl; Mostafa Afshar; Isidro Albert-García; Jon Forsberg; Marcus Ressner; Mathias Elgland; Veronica Sanchez-Rodriguez; Firas Aljabery; Miguel Ochoa-Figueroa

作者单位1. Department of Clinical and Experimental Medicine, Division of Urology, Linköping University, Linköping, Sweden; 2. Department of Radiology in Linköping, Department of Health, Medicine and Caring Sciences, Linköping University, Linköping, Sweden; 3. Curium Pharma (Nordics), Curium Pharma Finland OY, Helsinki, Finland; 4. Clinical Department of Medical Radiation Physics, Region Östergötland, Linköping, Sweden; 5. Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden; 6. Department of Clinical Physiology in Linköping, Department of Health, Medicine and Caring Sciences, Linköping University, Linköping, Sweden; 7. Department of Nuclear Medicine and Medical Radiation Physics, Karolinska University Hospital, Stockholm, Sweden; 8. Department of Radiology, Section for Molecular Imaging, Institution for Surgical Sciences, Uppsala University Hospital, Uppsala, Sweden; 9. Center for Medical Image Science and Visualization (CMIV), Linköping University, Linköping, Sweden

PDF源文件 DOI 网页
190 天

Preclinical evaluation of [ 18 F]fluoroethylresorufin as PET tracer for cerebral amyloid angiopathy

作者Daniel Bleher; Marilena Poxleitner; Ann-Kathrin Grotegerd; Oliver Hihn; Laura Kuebler; Gregory Bowden; Martin Schaller; Florian C. Maier; Bettina Weigelin; Bernd J. Pichler; Andreas Maurer; Kristina Herfert

作者单位1. Werner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, University of Tübingen, Tübingen, Germany; 2. Cluster of Excellence iFIT (EXC 2180) Image Guided and Functionally Instructed Tumor Therapies, University of Tübingen, Tübingen, Germany; 3. Department of Dermatology, University of Tübingen, Tübingen, Germany

PDF源文件 DOI 网页
107 天

Sarcopenia does not affect total liver function measured using technetium-99m mebrofenin hepatobiliary scintigraphy

作者Pieter Arntz; Pim Olthof; Fadi Rassam; Roelof Bennink; Robert-Jan Coelen; Thomas van Gulik; Jan Heil; Geert Kazemier; Bart Takkenberg; Joris Erdmann

作者单位1. Cancer Center Amsterdam, Amsterdam UMC, Department of Surgery, University of Amsterdam, VUMC, Amsterdam, The Netherlands; 2. Department of Surgery, Erasmus MC Cancer Institute, Rotterdam, The Netherlands; 3. Cancer Center Amsterdam, Amsterdam UMC, Department of Radiology and Nuclear Medicine, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands; 4. Department of General, Visceral and Transplant Surgery, University Hospital Frankfurt, Goethe-University Frankfurt, Frankfurt am Main, Germany; 5. Cancer Center Amsterdam, Amsterdam UMC, Department of Surgery, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands; 6. Location Academic Medical Center, Department of Gastroenterology and Hepatology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands

PDF源文件 DOI 网页
127 天

Radioluminescence microscopy of tumor organoids enabled by a reconfigurable high-resolution imaging setup

作者Sofia Demianova; Martin Dierolf; Maximilian Reichert; Laura Schmidleitner; Franz Pfeiffer; Wolfgang A. Weber

作者单位1. Chair of Biomedical Physics, Department of Physics, TUM School of Natural Sciences, Technical University of Munich, Garching, Germany; 2. Munich Institute of Biomedical Engineering (MIBE), Technical University of Munich, Garching, Germany; 3. Center for Translational Pancreatic Cancer Research, TUM School of Medicine and Health, Clinical Department for Internal Medicine II, TUM University Hospital, Munich, Germany; 4. Center for Organoid Systems (COS), Technical University of Munich, Garching, Germany; 5. TUM Institute for Advanced Study, Technical University of Munich, Garching, Germany; 6. Department of Nuclear Medicine, TUM University Hospital, Klinikum rechts der Isar, Munich, Germany; 7. Bavarian Cancer Research Center (BZKF), Munich, Germany

PDF源文件 DOI 网页

Expert Matching · Case Demo

把投稿要求,转成可验证的期刊方案

说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。

CrushSCI 在线

客户询问

我是环境工程专业,需要一篇 SCI,希望 3 个月内见刊。没有基金,也没有大牛挂名,可以投哪些期刊?

CrushSCI回复

可以。先按 90 天时限做可行性筛选,同步查找无基金、无知名作者挂靠的典型论文案例,作为选刊依据。重点核对研究质量与期刊 scope。

拟题建议
《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》

样本口径2026 年最近 5 篇有效论文样本

平均审稿96.4 天

中位数77 天

Contact CrushSCI

联系 CrushSCI

扫码添加微信,或留下手机号/微信号,我们将与你确认稿件阶段、编辑需求和投稿计划。

当前选择:论文编辑服务

也可以预留联系方式

手机号和微信号至少填写一项,仅用于本次咨询联系,不会公开。